Latest Licensing News

News Corp posted a 7% revenue increase to $9.028 billion in fiscal 2026, driven by gains across its key segments, while net income attributable to stockholders fell 51% due to absence of prior discontinued operations income.

Iris Cairns Property Trust has secured over 80% of Reef Casino Trust units, making its $3.87 per unit takeover offer unconditional and setting a firm 14 August deadline without extension.

EVE Health Group has progressed its Libbo pilot clinical study for erectile dysfunction with dosing set for Q4 2026 and achieved a major solubility breakthrough for apixaban, while appointing Ben Rohr as CEO to drive commercial growth.

Argent BioPharma's licensing partner Splash Beverage Group has launched the US veterinary development program for CannEpil®, targeting companion-animal oncology and chronic pain. Led by industry veteran Dr Hunter Land, the initiative follows a defined FDA regulatory pathway and could broaden CannEpil®’s commercial footprint beyond human neurology.

Peako Limited has identified extensive, high-grade gold-bearing veins across its Saudi Arabian projects, including an 8km corridor at Wadi Jarir with samples up to 41.5 g/t gold, setting the stage for maiden drilling this October.

Acrux Limited spotlighted its Female Testosterone Metered Dose Transdermal System (MDTS) at the Bioshares Biotech Summit, revealing positive Phase II data and outlining a clear regulatory and commercial roadmap targeting Hypoactive Sexual Desire Disorder (HSDD) in women.

Dimerix CEO Dr Nina Webster detailed the company’s geographic and product diversification at the Bioshares Summit, spotlighting the commercial potential of DMX-200 and the newly acquired Phase 2 asset DMX-652 targeting acute kidney injury.

Lithium Universe Limited has secured $900,000 through a placement with existing investors to fund working capital and progress key projects including the Brownsville Lithium Refinery PFS and innovative metal recycling technologies.

Credit Corp delivered a 12% profit rise to a record $105.5 million in FY2026, powered by a 57% surge in US debt buying earnings and a strategic entry into UK consumer lending.

Audeara has reached a key milestone as its chip-level AI licensing partnership with Optek enters commercial production, receiving initial purchase orders worth about A$31,000. This validates Audeara’s scalable fee-per-chip licensing model and sets the stage for broader applications in audio and hearing health.

Reckon Limited maintained steady revenue and EBITDA in constant currency during the first half of FY26, while NPAT rose 6%, driven by strong growth in its cloud products Reckon One and Billing Workflows alongside strategic AI investments.

Peregrine Gold has expanded the known gold-bearing paleo gravel strike at its Capricorn Prospect to approximately 4 kilometres, uncovering a new potential gold source and advancing plans for small-scale mining operations.